Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solithromycin for Airway Inflammation in COPD
NCT02628769Phase 2Terminated
- Sponsor
- Imperial College London
- Start
- Jul 2015
- Primary completion
- Jan 2017
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of solithromycin in chronic obstructive pulmonary disease (COPD), sponsored by Imperial College London. Started Jul 2015; status: terminated.
02
Drugs
solithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02628769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02628769.